Results 1 to 10 of about 123,112 (260)

Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial—Lysosomal Axis [PDF]

open access: yesCells, 2021
Lysosomal storage disease (LSD) is an inherited metabolic disorder caused by enzyme deficiency in lysosomes. Some treatments for LSD can slow progression, but there are no effective treatments to restore the pathological phenotype to normal levels ...
Myeong Uk Kuk   +5 more
doaj   +3 more sources

Pompe Disease: New Developments in an Old Lysosomal Storage Disorder [PDF]

open access: goldBiomolecules, 2020
Pompe disease, also known as glycogen storage disease type II, is caused by the lack or deficiency of a single enzyme, lysosomal acid alpha-glucosidase, leading to severe cardiac and skeletal muscle myopathy due to progressive accumulation of glycogen ...
Naresh K. Meena, Nina Raben
doaj   +3 more sources

Effect of disease progression on CSF-directed AAV gene therapy in a large brain animal model of lysosomal storage disease [PDF]

open access: yesMolecular Therapy: Methods & Clinical Development
The lysosomal storage disease alpha-mannosidosis (AMD) is caused by a genetic deficiency of lysosomal alpha-mannosidase, leading to the widespread presence of storage lesions in the brain and other tissues.
Jacqueline E. Hunter   +6 more
doaj   +2 more sources

Niemann-Pick Disease: An Underdiagnosed Lysosomal Storage Disorder [PDF]

open access: goldCase Reports in Genetics, 2019
Lysosomal storage disorders (LSDs) collectively constitute a significant public health burden in developing countries. Commoner LSDs include Gaucher, Fabry, and Niemann-Pick disease (NPD), but many cases remain undiagnosed.
Inusha Panigrahi   +6 more
doaj   +2 more sources

Positioning Head Tilt in Canine Lysosomal Storage Disease: A Retrospective Observational Descriptive Study. [PDF]

open access: goldFront Vet Sci, 2021
Tamura S   +7 more
europepmc   +2 more sources

Reactivation of mTOR signaling slows neurodegeneration in a lysosomal sphingolipid storage disease

open access: goldNeurobiology of Disease
Sandhoff disease, a lysosomal storage disorder, is caused by pathogenic variants in the HEXB gene, resulting in the loss of β-hexosaminidase activity and accumulation of sphingolipids including GM2 ganglioside.
Hongling Zhu   +8 more
doaj   +2 more sources

TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency [PDF]

open access: yesScientific Reports
Progranulin is a pro-protein that is necessary for maintaining lysosomal function. Loss-of-function progranulin (GRN) mutations are a dominant cause of frontotemporal dementia (FTD).
Wren O. Nader   +14 more
doaj   +2 more sources

Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?

open access: goldMolecular Genetics and Metabolism Reports, 2017
Chronic intestinal pseudo-obstruction results in clinical manifestations that resemble intestinal obstruction but in the absence of any physical obstructive process.
J. Politei   +5 more
doaj   +2 more sources

Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients. [PDF]

open access: goldFront Immunol, 2019
Pereira CS   +19 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy